International Stem Cell
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of International Stem Cell generated cash of $929,000, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore $846,000.
Cash Flow
| 2014 | -6.41M | -987K | 6.27M |
|---|---|---|---|
| 2015 | -4.12M | -738K | 4.27M |
| 2016 | -4.19M | -943K | 4.71M |
| 2017 | -2.14M | -864K | 3.2M |
| 2018 | -1.08M | -661K | 2.51M |
| 2019 | -1.39M | -494K | 1.3M |
| 2020 | -341K | -108K | 654K |
| 2021 | -1.29M | -45K | 824K |
| 2022 | 332K | -11K | 250K |
| 2023 | 929K | -83K | 0 |
ISCO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 742K | 171K | 689K | 484K | 1.07M | 304K | 110K | 532K | 1.11M | 2.24M |
Operating activities | ||||||||||
Net income | -131K | -331K | -899K | -2.72M | -4.26M | -2.13M | -6.06M | -1.07M | -2.63M | -12.47M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 194K | 218K | 262K | 253K | 285K | 308K | 326K | 331K | 472K | 458K |
Stock-based compensation expense | 464K | 399K | 644K | 1.27M | 2.08M | 0 | 1.38M | 972K | 597K | 1.72M |
| Deferred income tax benefit | 464K | 399K | 644K | 1.27M | 2.08M | 0 | 1.38M | 972K | 597K | 1.72M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 173K | 97K | -441K | 1.11M | -864K | -186K | 109K | -27K | -86K | -147K |
Inventories | 141K | -114K | -268K | 316K | 123K | -287K | -129K | -157K | -217K | -215K |
Accounts payable | 42K | -186K | 148K | -294K | 196K | -92K | -11K | -251K | 422K | 138K |
Cash generated by operating activities | 929K | 332K | -1.29M | -341K | -1.39M | -1.08M | -2.14M | -4.19M | -4.12M | -6.41M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -80K | -11K | -45K | -108K | -494K | -661K | -864K | -944K | -738K | -988K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 | 0 |
Cash generated by investing activities | -83K | -11K | -45K | -108K | -494K | -661K | -864K | -943K | -738K | -987K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 4K | 500K | 500K | 105K | 105K | 3.64M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 250K | -824K | -654K | 1.3M | -2M | 2.7M | -700K | 3.11M | 0 |
Cash used in financing activities | 0 | 250K | 824K | 654K | 1.3M | 2.51M | 3.2M | 4.71M | 4.27M | 6.27M |
Net Change In Cash | 846K | 571K | -518K | 205K | -591K | 771K | 194K | -422K | -579K | -1.13M |
Cash at end of period | 1.58M | 742K | 171K | 689K | 484K | 1.07M | 304K | 110K | 532K | 1.11M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |